Patents Assigned to Novelix Pharmaceuticals, Inc.
  • (Pyrroloquinoxalinyl) pyrazinecarbohydrazide-oxalic acid co-crystal for treatment of cancer and other diseases
    Patent number: 8058437
    Abstract: A novel co-crystal of N?-(7-fluoropyrrolo[1,2a]quinoxalin-4-yl)pyrazine-2-carbohydrazide with oxalic acid is disclosed. The disclosed oxalic acid co-crystal demonstrates cancer cell growth inhibition and is more bioavailable than the corresponding free base when administered as a suspension.
    Type: Grant
    Filed: April 8, 2009
    Date of Patent: November 15, 2011
    Assignee: Novelix Pharmaceuticals, Inc.
    Inventors: Victor J Bauer, Mike H O'Neill, Barbara J Kidon, Burkhard Jansen
  • COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION AND HYPERKERATOTIC LESIONS
    Publication number: 20110077297
    Abstract: A method of treating inflammation and hyperkeratotic lesions in a mammal in need thereof, by administering the following compound (NVX-207), a related compound, or a pharmaceutically acceptable salt thereof to the mammal.
    Type: Application
    Filed: May 28, 2009
    Publication date: March 31, 2011
    Applicant: NOVELIX PHARMACEUTICALS, INC.
    Inventor: Burkhard Jansen
  • NOVEL (PYRROLOQUINOXALINYL) PYRAZINECARBOHYDRAZIDE-OXALIC ACID CO-CRYSTAL FOR TREATMENT OF CANCER AND OTHER DISEASES
    Publication number: 20110034473
    Abstract: A novel co-crystal of N?-(7-fluoropyrrolo[1,2a]quinoxalin-4-yl)pyrazine-2-carbohydrazide with oxalic acid is disclosed. The disclosed oxalic acid co-crystal demonstrates cancer cell growth inhibition and is more bioavailable than the corresponding free base when administered as a suspension.
    Type: Application
    Filed: April 8, 2009
    Publication date: February 10, 2011
    Applicant: NOVELIX PHARMACEUTICALS, INC.
    Inventors: Victor J. Bauer, Mike H. O'Neill, Barbara J. Kidon, Burkhard Jansen
  • Methods and compositions for inhibiting tumor growth
    Patent number: 7851462
    Abstract: The present invention relates to novel betulinic acid derivatives with increased activity for the treatment of carcinomas and HIV diseases, a method for preparing such novel betulinic acid derivatives as well as their use as pharmaceuticals.
    Type: Grant
    Filed: December 21, 2007
    Date of Patent: December 14, 2010
    Assignee: Novelix Pharmaceuticals, Inc.
    Inventors: Edgar Selzer, Burkhard Jansen, Reinhard Paschke
  • METHODS AND COMPOSITIONS FOR INHIBITING TUMOR GROWTH
    Publication number: 20080214516
    Abstract: The present invention relates to novel betulinic acid derivatives with increased activity for the treatment of carcinomas and HIV diseases, a method for preparing such novel betulinic acid derivatives as well as their use as pharmaceuticals.
    Type: Application
    Filed: December 21, 2007
    Publication date: September 4, 2008
    Applicant: Novelix Pharmaceuticals, Inc.
    Inventors: Edgar Selzer, Burkhard Jansen, Reinhard Paschke
  • Methods and compositions for inhibiting tumor growth
    Patent number: 7312205
    Abstract: The present invention relates to novel betulinic acid derivatives with increased activity for the treatment of carcinomas and HIV diseases, a method for preparing such novel betulinic acid derivatives as well as their use as pharmaceuticals.
    Type: Grant
    Filed: February 11, 2004
    Date of Patent: December 25, 2007
    Assignee: Novelix Pharmaceuticals, Inc.
    Inventors: Edgar Selzer, Burkhard Jansen, Reinhard Paschke
  • Medicament for inhibiting tumour growth
    Publication number: 20060194774
    Abstract: The present invention relates to novel betulinic acid derivatives with increased activity for the treatment of carcinomas and HIV diseases, a method for preparing such novel betulinic acid derivatives as well as their use as pharmaceuticals.
    Type: Application
    Filed: February 11, 2004
    Publication date: August 31, 2006
    Applicant: Novelix Pharmaceuticals, Inc.
    Inventors: Edgar Selzer, Burkhard Jansen, Reinhard Paschke